Obesity-Related Glomerulopathy and Newly Diagnosed Type 2 Diabetes in Advanced CKD: A Case Report

Background: Obesity-related glomerulopathy (ORG) is characterised by glomerulomegaly, with or without an adaptive focal segmental glomerulosclerosis lesion, and its incidence is rising in parallel with the obesity epidemic. Case presentation: We report the case of a 43-year-old man with class III obesity (body mass index 40.2 kg/m²) and a 20-year history of arterial hypertension who was referred for newly detected renal impairment. He was admitted with elevated serum creatinine (261 µmol/L, eGFR 26 mL/min/1.73 m²), moderately increased proteinuria (UPCR 172.6 mg/mmol) with normal serum albumin, urinary sediment without erythrocyturia, and features of metabolic syndrome. An oral glucose tolerance test and HbA1c confirmed previously undiagnosed type 2 diabetes mellitus. Kidney biopsy showed glomerulomegaly with the perihilar variant of FSGS, superimposed on moderate arteriosclerosis and 40–50% interstitial fibrosis and tubular atrophy, without nodular diabetic glomerulosclerosis or electrondense immune deposits. Although electron microscopy showed diffuse foot-process effacement, the integrated clinicopathological findings supported ORG. After adding empagliflozin to renin–angiotensin–aldosterone system blockade, along with dietary and lipid-lowering measures, proteinuria decreased (urine protein/creatinine ratio from 172.6 to 132.8 mg/mmol), and kidney function remained stable. Conclusion: This case highlights the role of kidney biopsy in patients with obesity and advanced CKD in identifying coexisting lesions, interpreting ultrastructural findings in clinical context, and screening for diabetes in patients with CKD.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-18
DOI
https://doi.org/10.20944/preprints202611.1813.v1
Primary Topic
Chronic Kidney Disease and Diabetes
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Obesity-Related Glomerulopathy and Newly Diagnosed Type 2 Diabetes in Advanced CKD: A Case Report

Karol Graňák, Matej Vnučák, Ivana Dedinská, Patrícia Kleinová et al.
Preprints.org
Chronic Kidney Disease and Diabetes
preprint

Obesity-Related Glomerulopathy and Newly Diagnosed Type 2 Diabetes in Advanced CKD: A Case Report

Karol Graňák, Matej Vnučák, Ivana Dedinská, Patrícia Kleinová, Tímea Jusková
preprint en

Abstract

Background: Obesity-related glomerulopathy (ORG) is characterised by glomerulomegaly, with or without an adaptive focal segmental glomerulosclerosis lesion, and its incidence is rising in parallel with the obesity epidemic. Case presentation: We report the case of a 43-year-old man with class III obesity (body mass index 40.2 kg/m²) and a 20-year history of arterial hypertension who was referred for newly detected renal impairment. He was admitted with elevated serum creatinine (261 µmol/L, eGFR 26 mL/min/1.73 m²), moderately increased proteinuria (UPCR 172.6 mg/mmol) with normal serum albumin, urinary sediment without erythrocyturia, and features of metabolic syndrome. An oral glucose tolerance test and HbA1c confirmed previously undiagnosed type 2 diabetes mellitus. Kidney biopsy showed glomerulomegaly with the perihilar variant of FSGS, superimposed on moderate arteriosclerosis and 40–50% interstitial fibrosis and tubular atrophy, without nodular diabetic glomerulosclerosis or electrondense immune deposits. Although electron microscopy showed diffuse foot-process effacement, the integrated clinicopathological findings supported ORG. After adding empagliflozin to renin–angiotensin–aldosterone system blockade, along with dietary and lipid-lowering measures, proteinuria decreased (urine protein/creatinine ratio from 172.6 to 132.8 mg/mmol), and kidney function remained stable. Conclusion: This case highlights the role of kidney biopsy in patients with obesity and advanced CKD in identifying coexisting lesions, interpreting ultrastructural findings in clinical context, and screening for diabetes in patients with CKD.

Preprints.org
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon